Kenneth Blum | Dopaminedysregulation in Neurology | Best Researcher Award

Posted on by Pencis

Prof. Kenneth Blum: Dopaminedysregulation in Neurology

Kenneth Blum šŸ§¬šŸ”¬, a distinguished U.S. citizen šŸ‡ŗšŸ‡ø, Dopaminedysregulation in Neurology , boasts a robust academic journey culminating in a Ph.D. in Pharmacology from New York Medical College. With a wealth of expertise, he embarked on a fruitful postdoctoral stint at the Texas Biomedical Research Institute, delving into Psychopharmacology. Currently a Full Professor at Western University Health Sciences, his influence extends across diverse academic roles, including Adjunct Professor at Wright University and Research Professor Adjunct at the University of Vermont. Recognized as a trailblazer, he’s earned accolades like “Top 100 Scientist of the Year” and delivered keynote addresses globally, shaping the landscape of neuroscience and addiction research šŸŒšŸ§ .

Profile:

Scopus

šŸŽ“Ā Education:

Kenneth Blum šŸŽ“, a luminary in the field, earned his B.S. in Pharmacy from Columbia University in 1961 šŸ›ļø. He delved deeper into the realm of academia, achieving an M.S. in Medical Science from The University of Medicine and Dentistry of New Jersey in 1965 šŸ§Ŗ. Driven by passion, he secured a Ph.D. in Pharmacology from New York Medical College in 1968, guided by mentor Joseph Siefter šŸ§ . His journey continued with a pivotal postdoctoral stint at the Texas Biomedical Research Institute, focusing on Psychopharmacology in 1972 šŸŒ. Later, a Fellowship in Genetics at the University of Colorado School of Pharmacy in 1978 added another dimension to his illustrious career šŸ§¬.

šŸ„Ā Experience:

Kenneth Blum šŸŒšŸ§¬, a versatile professional, has left an indelible mark in academia and business. Notably appointed at the University of Texas Health Science Center at San Antonio, he contributed to various committees, including the Promotions Committee and International Relations Committee šŸŽ“. His leadership extends to diverse organizations, serving as Chairman for projects like the Hanging Bottle Research Project. In the business realm, Dr. Blum has held prominent roles, from Vice President of Research & Development at Zephra Corporation to Chairman & President of Pharmabyte Inc. His extensive advisory roles span across renowned entities like Weider International and PharmaVite Inc. šŸ¢šŸ”¬. As the Chief Scientific Officer for various healthcare centers, including Summit Estate Recovery Center and The Shores Recovery and Treatment Center, he continues to shape advancements in neurogenetics and addiction therapy. Currently, he holds the position of Executive Chairman at IngenEus, showcasing his enduring commitment to scientific innovation.

šŸ†Award & Honours:

 

Kenneth Blum šŸ…, a trailblazer in research and academia, boasts a plethora of prestigious honors and awards spanning his illustrious career. Recognized as the “Top 100 Registry Scientist of the Year” in 2019, he has graced global stages as a keynote speaker, addressing influential conferences on neuroscience, addiction, and genetics šŸ—£ļøšŸŒ. With a lifetime of achievements, Dr. Blum’s accolades include the “Who’s Who” Lifetime Achievement Award, the American Society of Addiction Medicine Millennium Lab Award, and the Julius Axelrod Distinguished Speaker Award. His impact extends beyond borders, with awards like the Titan Award and Marquis Who’s Who in America recognizing his expertise and contributions to addiction research šŸŒŸšŸ§¬.
šŸ’”Research Scholarships:

Kenneth Blum šŸ§¬šŸ”, a prolific researcher, has secured an impressive array of grants and contracts throughout his career, showcasing his commitment to advancing scientific knowledge. Notable achievements include his work on the “Psychogenetics of Drug Seeking Behavior” funded by NIDA, exploring genetic aspects of substance abuse šŸ’ŠšŸ§¬. Dr. Blum’s contributions extend to areas like alcoholism, hormones, and menopause, with grants from entities such as the Seaver Foundation and the Southwest Research Institute šŸ·šŸ¤°. His diverse research portfolio, spanning from the analysis of psychoactive drugs to finding genetic links to alcoholism, reflects a lifelong dedication to unraveling complex scientific puzzles šŸ”¬šŸŒ.

šŸ”¬Publications:
  1. The Future is Now for Precision Genomic Addiction Medicine as a Front-line Modality for Inducing ā€œDopamine Homeostasisā€ in Reward Deficiency Syndrome (RDS)
    • Authors: Gilley, E.D., Bowirrat, A., Gupta, A., Baron, D., Blum, K.
    • Year: 2024
  2. Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry
    • Authors: Blum, K., Ashford, J.W., Kateb, B., Makale, M., Gold, M.S.
    • Year: 2023
  3. Genetic Correlates as a Predictor of Bariatric Surgery Outcomes after 1 Year
    • Authors: Thanos, P.K., Hanna, C., Mihalkovic, A., Mastrandrea, L.D., Quattrin, T.
    • Year: 2023
  4. Preliminary Observations of Personalized Repetitive Magnetic Stimulation (PrTMS) Guided by EEG Spectra for Concussion
    • Authors: Makale, M.T., Nybo, C., Keifer, J., Thanos, P.K., Murphy, K.T.
    • Year: 2023
  5. Personalized repetitive transcranial magnetic stimulation (prtmsĀ®) for post-traumatic stress disorder (ptsd) in military combat veterans
    • Authors: Makale, M.T., Abbasi, S., Nybo, C., Dennen, C.A., Murphy, K.T.
    • Year: 2023
  6. The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research
    • Authors: Thanos, P.K., Hanna, C., Mihalkovic, A., Mastrandrea, L.D., Quattrin, T.
    • Year: 2023
  7. Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
    • Authors: Senior, D., Ahmed, R., Arnavut, E., Badgaiyan, R.D., Thanos, P.K.
    • Year: 2023
  8. Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapyā€”A Case-Series
    • Authors: Bajaj, A., Han, D., Elman, I., Barh, D., Blum, K.
    • Year: 2023
  9. Futuristic Exploration of Addiction Neuroscience in the Genomic Era
    • Authors: Blum, K., Elman, I., Bowirrat, A., Badgaiyan, R.D., Gold, M.S.
    • Year: 2023
  10. Neurogenetics and Epigenetics of Loneliness
    • Authors: Bowirrat, A., Elman, I., Dennen, C.A., Murphy, K.T., Blum, K.
    • Year: 2023

 

 

 

 

 

 

Anita Quintana | Neural development | Best Researcher Award

Posted on by Pencis
Anita Quintana Leading in Neural development

šŸ”¬ Dr. Anita Quintana is an accomplished scientist and educator, currently serving as an Associate Professor at the University of Texas at El Paso in the Department of Biological Sciences since 2021. With a Ph.D. in Neural Development and Biomedical Sciences with Distinction from the University of New Mexico in 2010, her expertise lies in the intricate realm of neural development. Prior to her current role, Dr. Quintana held the position of Assistant Professor from 2015 to 2021 in the same department. A dedicated academic, she has made significant contributions to the field, blending research and teaching seamlessly. Her passion for unraveling the mysteries of neural development is evident in her impactful work and commitment to shaping the next generation of scientists. šŸ§ šŸ‘©ā€šŸ”¬ šŸ“ššŸ”¬

Profile:

Scopus

Orcid

Education:

šŸŽ“ Dr. Anita Quintana boasts an impressive educational journey that laid the foundation for her illustrious career. In 2010, she proudly earned her Ph.D. from the University of New Mexico, specializing in Biomedical Sciences with Distinction. šŸ† This significant academic achievement marked the culmination of her dedicated pursuit of knowledge in the intricacies of biomedical research.

Prior to her doctoral pursuits, Dr. Quintana embarked on her academic voyage at New Mexico State University, where she obtained her Bachelor of Science degree in 2005. šŸŒ± Her undergraduate years at NMSU served as the fertile ground for her passion for the biological sciences, setting her on the path to becoming the esteemed educator and researcher she is today. šŸš€ With a solid academic foundation, Dr. Quintana continues to make impactful contributions to the field, shaping the future of Biological Sciences through her expertise and dedication. šŸ§¬šŸ”

Work Experience:

šŸ“š Dr. Anita Quintana’s dynamic academic repertoire at the University of Texas at El Paso reflects her commitment to shaping future scientists. From guiding students through the fundamentals of General Biology (BIOL 1305) to delving into the intricacies of Developmental Neurobiology (BIOL 4395), she enriches minds. šŸ§  Her collaborative spirit shines in team-taught courses like Intro Neuroscience (BIOL 2340) and Adv. Topics in Mol. Biochem. (CBCH 4320). šŸ¤ Driven by a passion for research, she mentors through Special Problems (BIOL 4198, 4298), engages in Advanced Scientific Writing (BIOL 5301), and leads Graduate Gene Regulation (BIOL 6303). šŸŒ± Her dedication extends to mentoring theses, dissertations, and independent research, fostering a vibrant academic community. šŸŽ“āœØ

Awards and Achievements:

šŸ† Dr. Anita Quintana’s accolades and leadership roles illuminate a distinguished career. As the GRC Carl Storm Underrepresented Minority Fellowship Awardee in 2023, she continues to break barriers. šŸŒŸ Serving as Co-Director of the CPRIT Institutional Post-Doctoral Training Program and Program Director for the Biosciences Doctoral Program, she shapes the next generation of researchers. šŸ’” Notably, she received the Shiloff Family Foundation Award and was honored as Mejor mentor en ciencia (Mentoring Award) at Vanderbilt University. šŸ… Recognized as one of the 100 Most Influential Hispanic/Latinx Faculty, her impact reverberates through mentoring, research, and a cascade of awards that celebrate excellence in her students. šŸš€šŸ”¬

Publications: